# US 2014/0350483 A1 · Injections

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2014/0350483 A1
- Document ID: US20140350483A1
- Status: Published application
- Kind: A1
- Application number: 14/372,146
- Filed: 2013-01-28
- Published: 2014-11-27
- Earliest claimed: 2012-01-27
- Assignees: Stablepharma Ltd
- Applicants: Stablepharma LTD
- Inventors: Bruce Roser
- Web page: https://patentgrep.com/patent/US20140350483A1

## CPC

- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/122: {Foams; Dry foams (edible foams A61K9/0056)}
- A61L 31/026: {Ceramic or ceramic-like structures, e.g. glasses}
- A61L 31/125: {having a macromolecular matrix}
- A61L 31/146: {Porous materials, e.g. foams or sponges}
- A61M 5/178: Syringes
- A61M 5/3129: {Syringe barrels (A61M5/3205, A61M5/50 take precedence)}
- A61L 2300/438: Antigens
- A61M 5/3145: {Filters incorporated in syringes}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A syringe containing a compressible porous matrix, which compressible porous matrix has in it a pharmaceutical in a soluble glass, Methods of producing and using the syringe, and compressible porous matrix inserts for insertion into a syringe barrel are also provided.

## Claims

### Claim 1

A pharmaceutical syringe comprising a syringe barrel, the syringe barrel containing a compressible porous matrix, wherein the compressible porous matrix has in it a pharmaceutical in a soluble glass.

### Claim 2 (depends on 1)

The pharmaceutical syringe according to claim 1, wherein the compressible porous matrix in a non-compressed state occupies at least about 10% of the volume of the syringe barrel.

### Claim 3

(canceled)

### Claim 4 (depends on 1)

The pharmaceutical syringe according to claim 1, wherein the compressible porous matrix has a compressibility of about 2:1 or more.

### Claim 5 (depends on 1)

The pharmaceutical syringe according to claim 1, wherein a gap for the passage of air during venting of the syringe is present between the matrix and the inner wall of the syringe barrel.

### Claim 6 (depends on 1)

The pharmaceutical syringe according to any one of the claim 1, wherein the compressible porous matrix is in the form of an elongate block.

### Claim 7 (depends on 1)

The pharmaceutical syringe according to claim 1, wherein the compressible porous matrix is in the form of a block having a non-circular cross section.

### Claim 8 (depends on 7)

The pharmaceutical syringe according to claim 7 wherein the block has a rectangular cross section.

### Claim 9 (depends on 1)

The pharmaceutical syringe according to claim 1, wherein the compressible porous matrix is a foam, a sponge, or a fibrous body.

### Claim 10 (depends on 9)

The pharmaceutical syringe according to claim 9, wherein the compressible porous matrix is cellulose foam, polyurethane foam, or melamine foam.

### Claim 11 (depends on 1)

The pharmaceutical syringe according to claim 1, wherein the compressible porous matrix has a functional pore size of between:
a) 1 micron and 2 mm;
b) 10 micron and 1 mm; or
c) 10 micron and 100 micron.

### Claim 12 (depends on 1)

The pharmaceutical syringe according claim 1, wherein the porous matrix is hydrophilic for the application of water soluble glassy substances

### Claim 13 (depends on 1)

The pharmaceutical syringe according to claim 1, wherein the porous matrix is hydrophobic for the application of oil soluble glassy substances.

### Claim 14 (depends on 1)

The pharmaceutical syringe according to claim 1, wherein the pharmaceutical is stabilised in a soluble dry glass on the compressible porous matrix.

### Claim 15 (depends on 1)

The pharmaceutical syringe or compressible porous matrix insert according to claim 1, wherein the glass is an amino acid glass, a sugar glass, a hydrophobically modified sugar glass, a carbohydrate glass, or a mixture thereof.

### Claim 16 (depends on 15)

The pharmaceutical syringe according to claim 15 wherein the glass is a trehalose glass.

### Claim 17

A method of producing a compressible porous matrix insert comprising
contacting a compressible porous matrix with a solution of a glass-forming material, which solution contains a pharmaceutical, and
drying the solution to form a glass in the compressible porous matrix, which glass comprises the pharmaceutical.

### Claim 18 (depends on 17)

The method according to claim 17, comprising treating the compressible porous matrix with a blocking agent before contacting the matrix with the solution of glass-forming material containing the pharmaceutical.

### Claim 19 (depends on 17)

The method according to claim 17 comprising treating the porous matrix with a surfactant.

### Claim at position 20

20-23. (canceled)

### Claim 24 (depends on 1)

The pharmaceutical syringe according to claim 1, wherein the insert is fixed to the seal of a syringe plunger.
